These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31882997)

  • 41. Combined HIV-1 Envelope Systemic and Mucosal Immunization of Lactating Rhesus Monkeys Induces a Robust Immunoglobulin A Isotype B Cell Response in Breast Milk.
    Nelson CS; Pollara J; Kunz EL; Jeffries TL; Duffy R; Beck C; Stamper L; Wang M; Shen X; Pickup DJ; Staats HF; Hudgens MG; Kepler TB; Montefiori DC; Moody MA; Tomaras GD; Liao HX; Haynes BF; Ferrari G; Fouda GGA; Permar SR
    J Virol; 2016 May; 90(10):4951-4965. PubMed ID: 26937027
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection.
    Corthésy B; Bioley G
    Front Immunol; 2018; 9():431. PubMed ID: 29563912
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa.
    Cox E; Verdonck F; Vanrompay D; Goddeeris B
    Vet Res; 2006; 37(3):511-39. PubMed ID: 16611561
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dual-Isotope SPECT/CT Imaging of the Tuberculosis Subunit Vaccine H56/CAF01: Induction of Strong Systemic and Mucosal IgA and T-Cell Responses in Mice Upon Subcutaneous Prime and Intrapulmonary Boost Immunization.
    Thakur A; Rodríguez-Rodríguez C; Saatchi K; Rose F; Esposito T; Nosrati Z; Andersen P; Christensen D; Häfeli UO; Foged C
    Front Immunol; 2018; 9():2825. PubMed ID: 30555488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New generation of mucosal adjuvants for the induction of protective immunity.
    Yuki Y; Kiyono H
    Rev Med Virol; 2003; 13(5):293-310. PubMed ID: 12931340
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mucosal vaccines: recent progress in understanding the natural barriers.
    Borges O; Lebre F; Bento D; Borchard G; Junginger HE
    Pharm Res; 2010 Feb; 27(2):211-23. PubMed ID: 19953309
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus.
    Herremans TM; Reimerink JH; Buisman AM; Kimman TG; Koopmans MP
    J Immunol; 1999 Apr; 162(8):5011-8. PubMed ID: 10202050
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mucosal vaccines and technology.
    Miquel-Clopés A; Bentley EG; Stewart JP; Carding SR
    Clin Exp Immunol; 2019 May; 196(2):205-214. PubMed ID: 30963541
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent progress in mucosal vaccine development: potential and limitations.
    Lycke N
    Nat Rev Immunol; 2012 Jul; 12(8):592-605. PubMed ID: 22828912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Membrane-anchored CCL20 augments HIV Env-specific mucosal immune responses.
    Sun X; Zhang H; Xu S; Shi L; Dong J; Gao D; Chen Y; Feng H
    Virol J; 2017 Aug; 14(1):163. PubMed ID: 28830557
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Directing vaccine immune responses to mucosa by nanosized particulate carriers encapsulating NOD ligands.
    Pavot V; Climent N; Rochereau N; Garcia F; Genin C; Tiraby G; Vernejoul F; Perouzel E; Lioux T; Verrier B; Paul S
    Biomaterials; 2016 Jan; 75():327-339. PubMed ID: 26539801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
    Patel GB; Zhou H; Ponce A; Chen W
    Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of the nature of adjuvant and site of parenteral immunization on the serum and mucosal immune responses induced by a nasal boost with a vaccine alone.
    Guy B; Fourage S; Hessler C; Sanchez V; Millet MJ
    Clin Diagn Lab Immunol; 1998 Sep; 5(5):732-6. PubMed ID: 9729544
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses.
    Campo JD; Zayas C; Romeu B; Acevedo R; González E; Bracho G; Cuello M; Cabrera O; Balboa J; Lastre M
    Methods; 2009 Dec; 49(4):301-8. PubMed ID: 19410000
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies.
    Yasuda Y; Isaka M; Taniguchi T; Zhao Y; Matano K; Matsui H; Morokuma K; Maeyama J; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Jun; 21(21-22):2954-63. PubMed ID: 12798639
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In defense of mucosal surfaces. Development of novel vaccines for IgA responses protective at the portals of entry of microbial pathogens.
    McGhee JR; Mestecky J
    Infect Dis Clin North Am; 1990 Jun; 4(2):315-41. PubMed ID: 2189002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neonatal sublingual vaccination with Salmonella proteins and adjuvant cholera toxin or CpG oligodeoxynucleotides induces mucosal and systemic immunity in mice.
    Huang CF; Wang CC; Wu TC; Wu KG; Lee CC; Peng HJ
    J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):262-71. PubMed ID: 18376242
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccines against mucosal infections.
    Holmgren J; Svennerholm AM
    Curr Opin Immunol; 2012 Jun; 24(3):343-53. PubMed ID: 22580196
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans.
    Mestecky J; Michalek SM; Moldoveanu Z; Russell MW
    Behring Inst Mitt; 1997 Feb; (98):33-43. PubMed ID: 9382757
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rational application of nanoadjuvant for mucosal vaccine delivery system.
    Dewangan HK
    J Immunol Methods; 2020; 481-482():112791. PubMed ID: 32387695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.